Trusting-logo-2

For consortium members

News / Detailed article

Surveys Launch: Shaping the Future of the TRUSTING Monitoring Tool

TRUSTING is excited to announce the launch of two surveys under the “Survey for Evaluating Risk of Relapse in Mental Illness,” available in six languages: Czech, German, English, French, Dutch, and Turkish. These surveys aim to gather crucial insights that will influence the development of an innovative speech-based technology designed to predict psychotic relapses.

This important initiative seeks to collect data from both clinicians and patients separately, each survey taking approximately 5 – 15 minutes to complete. The goal is to understand current practices in relapse prediction and assess the potential use of an speech-based eHealth tool. The insights gained will be pivotal in tailoring the development of the TRUSTING  tool to better meet the needs of users and healthcare providers.

While the EPA and GAMIAN-Europe are responsible for collecting the responses, the valuable data derived from these surveys will guide the technological development and enhance in the first place our understanding of effective psychosis management strategies and enable in a later stage the development of other similar tools. These surveys aim to empower both patients and clinicians with a reliable, home-based application that can alert users to early signs of a potential relapse, facilitating timely and effective interventions.

We encourage clinicians to reflect on their current risk assessment methods, and patients to share their openness towards adopting new technologies in their daily lives.

Survey Links:

Deadline for both surveys: November 17th

For more details and to participate in the surveys, please visit our TRUSTING project page www.trusting-project.eu 

For questions concerning the surveys, including participants’ rights, please contact the EPA Office at epa.brussels@europsy.net and for general question please write us at info@trusting-project.eu 

*The surveys have been approved by the European Psychiatric Association (EPA) and the local ethical boards, ensuring that all data collection adheres to the highest ethical standards.